Vapreotide: Difference between revisions

Vapreotide
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Latest revision as of 01:16, 20 February 2025

A synthetic somatostatin analog used in medicine

Vapreotide is a synthetic somatostatin analog used primarily in the treatment of certain medical conditions such as esophageal varices and acromegaly. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.

Pharmacology[edit]

Vapreotide functions by binding to somatostatin receptors, which are G-protein-coupled receptors found throughout the body. This binding inhibits the secretion of various hormones, including growth hormone, insulin, and glucagon.

Mechanism of Action[edit]

The primary mechanism of action of vapreotide involves its interaction with somatostatin receptors, particularly the SSTR2 and SSTR5 subtypes. By activating these receptors, vapreotide reduces the release of growth hormone and other peptides, which can be beneficial in conditions like acromegaly and gastrointestinal bleeding.

Medical Uses[edit]

Vapreotide is used in the management of:

Acromegaly: A condition characterized by excessive growth hormone production, leading to enlarged bones and tissues.
Esophageal varices: Dilated veins in the esophagus that can bleed, often associated with liver cirrhosis.

Administration[edit]

Vapreotide is typically administered via intravenous or subcutaneous injection. The dosage and frequency depend on the specific condition being treated and the patient's response to therapy.

Side Effects[edit]

Common side effects of vapreotide include:

Related Pages[edit]

Vapreotide

@@ Line 1: / Line 1: @@
-'''Vapreotide''' is a synthetic [[somatostatin]] analog that is used in the management of [[acromegaly]], a rare hormonal disorder that results from an excess of [[growth hormone]] in the body. It is also used to treat symptoms associated with [[metastatic]] [[carcinoid tumors]] and vasoactive intestinal peptide secreting tumors (VIPomas).
+{{Short description|A synthetic somatostatin analog used in medicine}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 477002123
+| image = Vapreotide.svg
+| image2 = <!-- Another image if available -->
+}}
-== Pharmacology ==
+'''Vapreotide''' is a synthetic [[somatostatin]] analog used primarily in the treatment of certain medical conditions such as [[esophageal varices]] and [[acromegaly]]. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.
-Vapreotide, like natural somatostatin, inhibits the secretion of many hormones, including growth hormone, [[glucagon]], [[insulin]], and [[gastrin]]. It does this by binding to somatostatin receptors in the body, which are found in the [[pituitary gland]], the [[pancreas]], and certain parts of the [[stomach]] and [[intestines]]. By binding to these receptors, vapreotide inhibits the release of the aforementioned hormones, thereby helping to control symptoms in conditions where these hormones are overproduced.
+==Pharmacology==
+Vapreotide functions by binding to somatostatin receptors, which are G-protein-coupled receptors found throughout the body. This binding inhibits the secretion of various hormones, including [[growth hormone]], [[insulin]], and [[glucagon]].
-== Clinical Use ==
+===Mechanism of Action===
+The primary mechanism of action of vapreotide involves its interaction with somatostatin receptors, particularly the SSTR2 and SSTR5 subtypes. By activating these receptors, vapreotide reduces the release of growth hormone and other peptides, which can be beneficial in conditions like acromegaly and [[gastrointestinal bleeding]].
-Vapreotide is used in the treatment of acromegaly, a condition characterized by an overproduction of growth hormone, usually due to a benign tumor in the pituitary gland. By inhibiting the release of growth hormone, vapreotide can help to control the symptoms of this condition, which include enlarged hands and feet, facial changes, and joint pain.
+==Medical Uses==
+Vapreotide is used in the management of:
-In addition, vapreotide is used to manage symptoms associated with metastatic carcinoid tumors and VIPomas. These are types of neuroendocrine tumors that can cause a variety of symptoms, including flushing, diarrhea, and wheezing, due to the overproduction of certain hormones. Vapreotide can help to control these symptoms by inhibiting the release of these hormones.
+* [[Acromegaly]]: A condition characterized by excessive growth hormone production, leading to enlarged bones and tissues.
+* [[Esophageal varices]]: Dilated veins in the esophagus that can bleed, often associated with [[liver cirrhosis]].
-== Side Effects ==
+==Administration==
+Vapreotide is typically administered via [[intravenous]] or [[subcutaneous injection]]. The dosage and frequency depend on the specific condition being treated and the patient's response to therapy.
-Like all medications, vapreotide can cause side effects. The most common side effects include [[nausea]], [[pain]] at the injection site, [[gallstones]], and changes in [[blood sugar]] levels. In rare cases, vapreotide can cause serious side effects, such as [[heart problems]], [[liver problems]], and [[allergic reactions]].
+==Side Effects==
+Common side effects of vapreotide include:
-== See Also ==
+* [[Nausea]]
+* [[Diarrhea]]
+* [[Abdominal pain]]
+* [[Injection site reactions]]
+==Related Pages==
 * [[Somatostatin]]
+* [[Somatostatin receptor]]
 * [[Acromegaly]]
-* [[Carcinoid Syndrome]]
+* [[Esophageal varices]]
-* [[VIPoma]]
-[[Category:Drugs]]
+[[Category:Peptide hormones]]
+[[Category:Somatostatin analogs]]
 [[Category:Endocrinology]]
-[[Category:Pharmacology]]
+<gallery>
-{{Pharma-stub}}
+File:Vapreotide.svg|Vapreotide
+</gallery>